ArticleRSC advances2026
Augmenting the antimicrobial activity of clindamycin hydrochloride-loaded acrylate polymer/zinc oxide nanocomposites against pathogenic microbes.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our study's primary goal is to increase clindamycin hydrochloride's antibacterial efficacy by loading it into acrylate polymer/zinc oxide nanocomposites, which is among the most effective ways to accomplish controlled drug release to a precise targeted spot. Zinc oxide nanoparticles (ZnO NPs) were first made at room temperature (25 °C) using starch as a biopolymer stabilizer. The ZnO NPs were produced in almost spheres with an average particle size of 20 ± 2 nm that were verified using transmission electron microscopy (TEM), FT-IR, zeta potential and UV-vis absorbance. Green microemulsion polymerization techniques have been used in the field of polymer manufacturing to create advanced nanocomposites in an environmentally responsible manner. In order to encapsulate clindamycin hydrochloride as a medicinal drug, we have created zinc oxide nanoparticles (ZnO NPs) integrated into polymeric nanospheres made of poly(methyl methacrylate-
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.